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New Aspects of Thromboangiitis obliterans 
(von Winiwarter-Buerger's Disease) 
P. Berlit, C. Kessler, R. Reuther, K.-H. Krause 
Department of Neurology, Ruprecht-Karls-University, Heidelberg, FRG 
Key Words. Immunovasculitis- Immunohistochemical findings • Anti-elastin antibodies • 
IgE • Azathioprine 
Abstract. The existence of thromboangiitis obliterans as a clinical entity has been a matter 
of debate for many years. In contrast to other immunovasculitides there is no organ involve-
ment while peripheral vessels are affected. Heavy smokers under 40 years of age have a high 
predisposition for the disease. The cerebral form shows relapsing brain infarctions which can 
be visualized in CCT while panarteriography remains negative. Apart from unspecific inflam-
matory signs in blood and CSF there are distinctive laboratory findings proving the autoim-
munological character of von Winiwarter-Buerger's disease. In the serum anti-elastin anti-
bodies, IgE and anticollagen antibody activity are detectable. In 3 patients the authors 
detected specific immunohistochemical findings in a biopsy specimen of the temporal artery. 
In addition to platelet-inhibiting substances corticoids in acute and azathioprine in chronic 
treatment becomes necessary. 
In 1879, von Winiwarter in Vienna de-
scribed the segmental inflammatory chang-
ings in medium-sized arteries and veins in 
the amputated leg of a 57-year-old man, a 
disease he called endarteriitis obliterans. He 
underlined the possible role of coldness in the 
development of the gangrene in his case. 
Buerger [ 1908] changed the term endarteriitis 
into thromboangiitis obliterans and showed 
that the stenoses and occlusions in this dis-
ease are caused by repeated thromboses. In 
19 amputated legs he demonstrated as char-
acteristic findings the alternation of inflam-
matory thromboses in different states of de-
velopment and relatively normal segments in 
the single affected vessel. In these cases he 
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detected an increased prevalence in Jews of 
Russian or Polish origin. 
During the following years different 
authors named characteristic features of the 
disease: (1) A high predisposition for young 
men under 40 years of age. (2) The vessels of 
the wrist and hand are often included in 
the inflammatory process [Allen, 1929]. (3) 
There is a close association between cigarette 
smoking and the activity of the disease 
[Meyer, 1918; Silbert, 1945]. (4) There is 
often a migratory superficial thrombophlebi-
tis accompanying the vasculitis. 
But in spite of all these typical features the 
existence of thromboangiitis obliterans as a 
clinical entity has been questioned repeated-
ly. Especially the differentiation from inflam-
matory forms of arteriosclerosis gave cause 
for controversial opinions. One of the rea-
sons for this history of the disease may be the 
lack of organ involvement in von Winiwar-
ter-Buerger's disease, which is in contrast to 
almost all other immunovasculitides. In view 
of this fact it is not surprising that the cere-
bral form of thromboangiitis obliterans has 
been put in question even more than the 
peripheral disease. Jäger [1932] was the first 
to mention the existence of a cerebral in-
volvement in his cases, a few years later 
Spatz [1935] and Lindenberg and Spatz 
[1939] demonstrated two forms of cerebral 
thromboangiitis obliterans (CTAO): (1) mul-
tiple unsystematic cerebral infarctions in in-
volvement of medium-sized vessel, and (2) 
the symmetrical granular atrophy caused by 
involvement of small leptomeningeal ar-
teries. 
The significance of the second finding had 
been challenged early when Fisher [1957] and 
later Zollinger [1967] demonstrated that dif-
ferent forms of occlusive disease in the small 
endarteries of the brain result in the same 
picture. For neuropathologists the differenti-
ation between CTAO and arteriosclerosis 
was the cardinal problem. The differential 
diagnosis to other forms of cerebral vasculitis 
was not as big a problem because pathologi-
cal studies showed no involvement of the 
media or the elastica in the inflammatory 
process in CTAO. 
Which are the diagnostic criteria that 
could help us today in detecting CTAO? In 
the Neurologic Clinic in Heidelberg we saw, 
during a period of 12 years, 7 patients suffer-
ing from this disease (i.e. 0.05% of all pa-
tients and 0.3% of all brain infarctions be-
tween 1970 and 1982). All patients were 
young men and heavy smokers - the onset of 
neurological symptoms was usually before 
the thirtieth year. In 3 cases the neuropatho-
logical examination confirmed the diagnosis, 
posthumous. In 3 other patients whom we 
saw during the last 2 years extensive rheuma-
tological and immunological examinations 
could be carried out. 
In all patients there was an astonishing 
similarity of the clinical history. They all suf-
fered from repeated brain infarctions of dif-
ferent localization over months or even 
years. While in cranial computed tomogra-
phy (CCT) hypodensive areas according to 
the clinical neurological findings could be 
demonstrated, there were no pathological 
changes in the panarteriography of the brain-
supporting vessels. Extensive cardiological 
examinations including echocardiography 
and in 1 patient even a cardiac-catheter re-
vealed no possible source for repeating brain 
embolism from the heart. The areas of the 
medial and the posterior cerebral artery were 
the regions most often affected. The neuro-
logical signs as well as the CCT-findings im-
proved partially within few weeks leaving 
minor residual symptoms, especially visual 
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field reductions. Additional findings in 1 pa-
tient were major epileptic seizures and an 
ischemic optic neuritis [Kessler et al., 1984]. 
Another patient - a farmer - twice developed 
the brain infarctions during work outdoors 
[Kessler et al., 1983]. 
In all cases unspecific inflammatory 
changes in blood and/or cerebrospinal fluid 
(CSF) lead towards a vasculitic process. In 
CSF an increase of cells up to 100 cells/mm3 
as well as an increased protein concentration 
about 120 mg/100 ml could be demonstrated 
in several patients; in some patients at differ-
ent times of examination the findings were 
normal as well as pathological. Specific labo-
ratory findings were an increased titre of anti-
elastin antibodies of up to 1:1,400 (normal 
1:8) and an increased serum IgE of up to 
300 U/ml (normal range up to 100 U/ml). 
In 3 cases a biopsy of the temporal artery 
was performed. In all 3 patients there were 
distinct immunohistochemical findings while 
the pathohistological examination revealed a 
morphologically normal vessel wall. The re-
sults of the immunohistochemical examina-
tion with a direct immunofluorescent tech-
nique are shown in table I. An important 
result is the deposit of immunoglobulins and 
complement components especially in the 
vasa vasorum. Early investigators already 
suggested that the inflammation of the vasa 
vasorum might be the primary process in von 
Winiwarter-Buerger's disease [Buerger, 1908; 
Jäger, 1932]. The immunohistochemical 
findings as well as the increase of anti-elastin 
antibodies and IgE in the serum are signs of 
an autoimmunological process which one 
does not find in arteriosclerotic disease. In 20 
patients suffering from thrombotic brain in-
farctions anti-elastin antibody litres and se-
rum IgE were within the normal range. While 
the presence of anti-elastin antibodies in 
Table I. Immunohistochemical findings in a 
biopsy specimen of the temporal artery in 3 patients 
with CTAO 
IgG IgA IgM C l q C3b C3d C9 
Pat. 1 
Intima — — — + + + — 
Elastica interna — _ _ — — — _ 
Media _ _ _ _ _ _ _ 
Vas vasorum — + + + + — - — -
Pat. 2 
Int ima + + + + + + -
Elastica interna + + — + _ — _ 
Media _ _ _ _ _ _ _ 
Vas vasorum + + + + + + — + + — 
Pat. 3 
Intima + + + + + + -
Elastica interna + + _ — _ _ + 
Media _ _ _ _ _ _ _ 
Vas vasorum + + + + + + — + + -
CTAO seems to be a common and typical 
finding [Bollinger et al., 1979; Morsch et al., 
1978] the meaning of the increased IgE re-
mains unclear. This immunoglobulin is a 
sign of an allergic inflammatory process and 
often found in systemic vasculitis with respi-
ratory tract involvement [Berlit et al., 
1982]. 
Further studies are necessary to clarify the 
meaning of the immunohistochemical find-
ings in the vessel wall. But in young stroke 
patients the examination of a biopsy of the 
temporal artery could be a very helpful diag-
nostic procedure [Berlit and Kessler, 1983] in 
detecting CTAO. Two preconditions for this 
procedure are the panarteriography of the 
brain-supporting vessels performed in ad-
vance and a surgical technique for taking the 
biopsy specimen from a branch of the tempo-
ral artery. Taking the possible necessity of a 
later externa-interna bypass into consider-
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Table II . Clinical and laboratory findings in different vasculitides [modified after Berlit et al. 1983] 
Poly- Lupus Arteritis Allergic Wegener's Thromboangii t is 
arteritis erythematosus temporalis granulo- granulo- obliterans 
nodosa matosis matosis 
Clinical findings 
CNS ++ ++ + ++ + + 
PNS +++ + + ++ + 0 
Muscle +++ ++ +++ 0 + 0 
Kidney ++ ++ 0 + + + + 0 
Liver + + + + + 0 
Heart ++ ++ +_ +++ + 0 
Lung + + 0 + + + + + + 0 
Intestinal tract ++ ++ + + ++ 0 
Skin ++ +++ + ++ ++ 0 
Ankles ++ +++ ++ + + 0 
Peripheral vessels 0 + + + + + + + + + 
Age ~ 50-60 3CMÖ > 50 40^-50 4 0 - 5 0 ~ 25-35 
d:9 " 2:1 """" 1:3 ~ ~ 1:2 2,5:1 3:2 ~ 6:1 
Laboratory findings 
Erythrocyte sedimentat ion rate A A A A A A A A A A A A A 
Eosinophilia + 0 0 + + + + 0 
C-reactive protein ++ + + + + ++ 
Rheumatoid factor ++ ++ 0 + + 0 
Anti-elastin ant ibodies 0 - + + 0 - + + 0 0 0 + + + 
Immunoglobulin A A A A normal normal normal A A normal 
G normal A A A A normal A normal 
M normal normal A normal V normal 
E normal normal normal A A Ä Ä A A 
Complement C3 V V V V A normal normal normal 
C4 V V V A A normal normal A A 
HB s-ant igen/ant i-HB s + + 0 + 0 0 0 
CSFchangings ++ ++ + + 0-+ + 
Tissue antigens '> HLA-B8, A15 HLA-B8, A I 0 ? HLA-B8 HLA-A9, HLA-B5 
Immunohis tochemical ++ ++ +++ + ++ ++ 
findings in biopsy muscle skin temporal skin kidney temporal 
specimen from kidney artery lung artery 
+++ = Usually found; ++ = often found; + = seldom found; 0 = not found; A A A = usually increased; A A or V V = often 
increased or lowered; A or V = seldom increased or lowered. 
ation, the main stem of the vessel should be 
spared. 
In addition to these signs of humoral im-
mune mechanisms in thromboangiitis obli-
terans Adar et al. [1983] described an in-
creased stimulation index of cellular sensitiv-
ity to human collagen. All these findings are 
strong arguments for the distinctive charac-
ter of CTAO as an autoimmunological vas-
culitis. 
Another finding of interest is the greater 
prevalence of HLA-A9 and HLA-B5 antigens 
in patients with von Winiwarter-Buerger's 
disease [McLoughlin et al., 1976]. In consis-
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tence with the findings of Buerger [1908], the 
disease shows an increased occurrence in Is-
rael and the Orient. 
In the differential diagnosis of CT AO one 
has to think of focal encephalitis in septic 
brain embolism; a possible cardiac source of 
emboli to the brain should be excluded by 
echocardiography and long-term electrocar-
diography [Berlit, 1983]. The typical features 
of CT AO in comparison to some other vas-
culitides of the brain are summarized in ta-
ble II. There are some very distinctive diag-
nostic criteria that help to make a reasonably 
certain diagnosis of CT AO: (1) male patients, 
about 30 years old; (2) strong smokers; (3) 
relapsing brain infarctions in changing local-
izations, which can be visualized in CCT; (4) 
negative results in angiography and cardio-
logic examinations; (5) unspecific inflamma-
tory signs in blood (blood sedimentation rate, 
C-reactive protein) and CSF (cells and/or 
protein elevated); (6) anti-elastin antibodies, 
IgE and anticollagen antibody activity detect-
able; (7) distinctive immunohistochemical 
findings in biopsy of the temporal artery, and 
(8) signs or history of peripheral vessel in-
volvement. 
In therapy the autoimmunological charac-
ter of CTAO should be taken into account. 
Apart from the obligatory treatment with 
platelet-inhibiting substances corticoids in 
the acute situation of a brain infarction and 
azathioprine in long-term therapy are neces-
sary. Smoking must be strictly forbidden in 
patients with CTAO. 
Altogether the existence of thromboangii-
tis obliterans von Winiwarter-Buerger as a 
clinical entity has been defended by careful 
studies, and today the question asked by 
Ziilch [1969]: T h e cerebral form of von 
Winiwarter-Buerger's disease - does it exist' 
should be answered with 'yes'. 
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